Human guinea pigs in a London lab are to be given a form of the killer virus as the search for a lucrative jab hots up Sunday March 08 2020,… read more →
Open Orphan plc (“Open Orphan” or the “Company”) Positive results from Phase IIb field study of FLU-v vaccine (FLU-v 003), which has been developed by Imutex Limited, hVIVO’s 49% joint… read more →
How will this impact your development programs from a regulatory perspective. Get updates on the FDA guidance on Demonstrating Substantial Effectiveness and on Adaptive Trial Designs for clinical trials. Venn’s… read more →
Ellie Donnelly : January 7th 2020 – You can view this article at : independent.ie Long-term: CEO Cathal Friel says the deal meets a key objective Open Orphan, a Europe-focused… read more →
Contract signed with Carna Bioscience Venn Life Sciences, part of Open Orphan plc announce the signing of a contract with Carna Bioscience (“Carna”) (www.carnabio.com) for a First In Human Clinical… read more →